Anavex Life Sciences Corp (AVXL)

[BakedLangostino]

I hope you are right about 2024, but I think it'll be closer to 2025/2026 before we can fully appreciate the slow roll to protect IP, collect tons of evidentiary data to inform future research, and find the ideal partner.

2023 was about finishing the trial and collecting data. There may be a few things we're waiting on but that should be resolved by 1Q '24. Figure another few months to submit the paperwork and then 9-12 months for the FDA to review.

By then we'll also have the OLE data which may be sufficient to act as a P3 or P4 confirmatory. We'll see. But I think 2026 will be the year of major adoption and commercialization and that's when we can expect to see significant share price appreciation.

Europe may be a bit ahead of schedule because there's no need to negotiate with tons of independent insurers.

All of this hinges on FDA / EMA approval. It should be an eventful next 12 months on this message board.